Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis.
Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β.
Serum sickness reaction with skin involvement induced by bee venom injection therapy.
Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.
Satellite glial cells in dorsal root ganglia are activated in experimental autoimmune encephalomyelitis.
Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter.
Phase White Matter Signal Abnormalities in Patients with Clinically Isolated Syndrome and Other Neurologic Disorders.
HINT1 peptide/Hsp70 complex induces NK cell-dependent immunoregulation in a model of autoimmune demyelination.
[Multiple sclerosis: a comprehensive treatment and rehabilitation].
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis.
Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.
Grey matter damage in multiple sclerosis: A pathology perspective.
Automatic brain MR images diagnosis based on edge fractal dimension and spectral energy signature.
Non pharmacological interventions for spasticity in multiple sclerosis.
Interferon Beta and Long-term Disability in Multiple Sclerosis-Reply.
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.
Aquaporin-4 immuneglobulin g testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease.
[Antioxidant use as dietary therapy in patients with multiple sclerosis].
New opportunities of real world data from clinical routine settings in life cycle-management of drugs: example of an integrative approach in multiple sclerosis.
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Late-onset multiple sclerosis in South-East wales.
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report.
A web-based decision support tool for prognosis simulation in multiple sclerosis.
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
A(H1N1) vaccination recruits T lymphocytes to the choroid plexus for the promotion of hippocampal neurogenesis and working memory in pregnant mice.
Pages
« first
‹ previous
…
582
583
584
585
586
587
588
589
590
…
next ›
last »